Mr Mrs Miss Ms Dr Other

Ms
Sian
Hope

Senior IP Solicitor

London Office

Law

Telephone. +44(0) 207 776 5111
Email. shope@hgf-law.com
Vcard
Linkedin

Experience

Sian has expertise in IP litigation and non-contentious IP matters. She is passionate about life sciences and has primarily advised pharmaceutical clients across all stages of patent litigation.

In particular, Sian advises pharmaceutical and healthcare clients in relation to UK High Court and Court of Appeal matters (notably the high-stakes UK rivaroxaban (Xarelto) patent proceedings), as well as pan-European and UPC matters. She also assists clients in enforcing their soft-IP rights particularly in the retail sector.

She completed a BSc and LLB at Monash University in Australia, is a member of the NSW Law Society and is a Registered Foreign Lawyer in the UK.

Specialisms

Industries

Services

Qualifications

Solicitor

Other
Australia

BSC

Genetics & Molecular Biology

LLB

(Honours)

Publications

A leading case - beware sequence errors in patent claims

View publication online

UPC on Doctrine of Equivalents

View publication online

UPC stakes claim for wide-reaching long-arm jurisdiction for European patents

View publication online

Court of Appeal Confirms No Second Medical Use SPCs in UK

View publication online

A leading case – beware sequence errors in patent claims

View publication online

UPC on Doctrine of Equivalents

View publication online

UPC stakes claim for wide-reaching long-arm jurisdiction for European patents

View publication online

Court of Appeal Confirms No Second Medical Use SPCs in UK

View publication online

Related News

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article
Event - 4th November 2025

HGF are Silver Sponsors of LSPN Europe 2025

HGF is proud to be a Silver Sponsor of LSPN Europe 2025, a leading forum dedicated to helping life sciences innovators protect and leverage their intellectual property across the entire …

Event details
Event - 30th - 31st October 2025

RAPS European Digital Technologies and Software conference

HGF is proud to be attending the RAPS European Digital Technologies and Software conference in The Netherlands on 30th-31st October. HGF Partner and Patent Attorney Janine Swarbrick and Patent Director …

Event details

Protect It Before You Promote It: IP Advice for MedTech Innovators

Developed a new medical product? Check. Got tickets to an exciting MedTech conference to show off your new product? Check. Intellectual property? Pardon? In the excitement of bringing a new …

Read article

Agritech Thymes: The Bite of Implied Consent: Lessons from the Pink Lady Case

Can the supply of a plant variety without clear and defined restrictions on its use be an implicit consent to commercialise it? This case centres on the evidence required to …

Read article
See all updates

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.

Contact us